A carregar...
Adverse effects of SGLT2 inhibitors on bone
Sodium–glucose cotransporter 2 (SGLT2) inhibitors offer attractive metabolic and cardiorenal benefits for patients with type 2 diabetes, but are associated with a number of safety issues. A recent study documented that SGTL2 inhibition indirectly triggers the FGF23/1,25-dihydroxyvitamin D/parathyroi...
Na minha lista:
| Publicado no: | Nat Rev Nephrol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6138556/ https://ncbi.nlm.nih.gov/pubmed/29875481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41581-018-0028-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|